Crossmark

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-018-4146-7

Published Online: 2018-02-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Ming-Chun

Chen, Yi-Ju

Chiu, Tai-Jan

Lan, Jui

Liu, Chien-Ting

Chen, Yi-Ching

Tien, Hsin-Ho

Chen, Yen-Yang
Funding

Funding for this research was provided by:

Kaohsiung Chang Gung Memorial Hospital (CMRPG8E0881)

Kaohsiung Chang Gung Memorial Hospital (CMRPG8C0531)

Kaohsiung Chang Gung Memorial Hospital (CMRPG8D0801)
More Information

Article History

Received: 23 January 2017

Accepted: 19 February 2018

First Online: 27 February 2018

Ethics approval and consent to participate

: This study followed the World Medical Association Declaration of Helsinki recommendation and was approved by the Chang Gung Medical Foundation Institutional Review Board. Informed consent was obtained in written form from study all participants and the protocol for this study was approved by the Institutional Review Boards of Chang-Gung Medical Center (Taiwan) (IRB 103-7412B). Moreover, because this study was retrospective study in design and used archived material, it did not pose increased risk to the patients.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.